NEW YORK ( TheStreet) -- Igate Corporation (Nasdaq: IGTE) is trading at unusually high volume Tuesday with 1.4 million shares changing hands. It is currently at 4.1 times its average daily volume and trading up 70 cents (+6.3%) at $11.74 as of 3:27 p.m. ET.

Igate has a market cap of $776.2 million and is part of the technology sector and computer software & services industry. Shares are down 44% year to date as of the close of trading on Monday.

iGATE Corporation provides outsourced information technology (IT) and IT-enabled operations, solutions, and services. The company has a P/E ratio of 17, above the average computer software & services industry P/E ratio of 14.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Igate as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, reasonable valuation levels, expanding profit margins, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full Igate Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.
null

If you liked this article you might like

IGate (IGTE) Marked As A Barbarian At The Gate

IGate (IGTE) Marked As A Barbarian At The Gate

IGate (IGTE) Showing Signs Of Being Strong And Under The Radar

IGate (IGTE) Showing Signs Of Being Strong And Under The Radar

European Stocks Edge Up From 3-Month Lows; Bayer Sells Diabetes Division

European Stocks Edge Up From 3-Month Lows; Bayer Sells Diabetes Division

Water-Logged And Getting Wetter Stock Of The Day: IGate (IGTE)

Water-Logged And Getting Wetter Stock Of The Day: IGate (IGTE)

Nasdaq Backs Off Record High as Biotech Drags Markets Lower

Nasdaq Backs Off Record High as Biotech Drags Markets Lower